Moderna vaccine shows 94.1% efficacy in trial: Study

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3n334dk

Comments

Popular posts from this blog

CBSE to conduct Classes 10 and 12 Board exams 2024 from Feb 15 to April 10

Ukraine tests new Black Sea corridor amid attack on ports

Common University Entrance Test-Postgraduate results announced